PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27414036-0 2016 The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytes. Ditiocarb 27-49 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 128-134 9394024-11 1997 Diethyldithiocarbamate inhibited pentoxifylline formation by 85.7% in cDNA expressed CYP1A2. Ditiocarb 0-22 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 85-91 27414036-5 2016 Diethyldithiocarbamate-copper complex revealed inconsistent and rather modulatory effect on the expression of CYP1A2 and CYP3A4 in several cultures of human hepatocytes. Ditiocarb 0-22 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 110-116 21277363-4 2011 Fluvoxamine maleate, gemfibrozil, amiodarone hydrochloride, omeprazole, quinidine, diethyldithiocarbamic acid and ketoconazole were successfully applied as test inhibitors for CYP1A2, CYP2C8, CYP2C9, CYP2C19*1, CYP2D6*1, CYP2E1 and CYP3A4/5 in HLMs, respectively. Ditiocarb 83-109 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 176-182 20081260-0 2009 Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes. Ditiocarb 10-32 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 58-64 20081260-0 2009 Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes. Ditiocarb 34-37 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 58-64 20081260-4 2009 A comparative in vitro study provides clear evidence that ticlopidine and DDC, applied at concentrations that inhibit the above-mentioned CYP isoforms, potently (as compared to furafylline) inhibit human CYP1A2 and caffeine metabolism, in particular 1-N- and 3-N-demethylation. Ditiocarb 74-77 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 204-210 18950609-12 2009 Results with the isoform-selective inhibitors suggest that the isoforms inhibited by ketoconazole (mainly CYP3A4) and diethyldithiocarbamate (mainly CYP2A6, and CYP2E1), but not the isoforms inhibited by furafylline (mainly CYP1A2), sulfaphenazole (mainly CYP2C9) and quinidine (mainly CYP2D6) are involved in the metabolic activation of AFB1. Ditiocarb 118-140 cytochrome P450 family 1 subfamily A member 2 Homo sapiens 224-230